These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 8382971)

  • 21. Regulation of fibrinolysis by C-terminal lysines operates through plasminogen and plasmin but not tissue-type plasminogen activator.
    Silva MM; Thelwell C; Williams SC; Longstaff C
    J Thromb Haemost; 2012 Nov; 10(11):2354-60. PubMed ID: 22974122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R; Geiger M; de Vries C; Pannekoek H; Binder BR
    J Biol Chem; 1991 Feb; 266(4):2227-32. PubMed ID: 1824940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction of plasminogen and fibrin in plasminogen activation.
    Wu HL; Chang BI; Wu DH; Chang LC; Gong CC; Lou KL; Shi GY
    J Biol Chem; 1990 Nov; 265(32):19658-64. PubMed ID: 2174048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E.
    Stewart RJ; Fredenburgh JC; Weitz JI
    J Biol Chem; 1998 Jul; 273(29):18292-9. PubMed ID: 9660794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. On the interaction of the finger and the kringle-2 domain of tissue-type plasminogen activator with fibrin. Inhibition of kringle-2 binding to fibrin by epsilon-amino caproic acid.
    van Zonneveld AJ; Veerman H; Pannekoek H
    J Biol Chem; 1986 Oct; 261(30):14214-8. PubMed ID: 3021732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding of tissue plasminogen activator to endothelial cells. The effect on functional properties. Localization of a ligand in the B-chain of tPA.
    Cheng XF; Brohlin M; Pohl G; Bäck O; Wallén P
    Thromb Res; 1995 Jan; 77(2):149-64. PubMed ID: 7740507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of nonproteolytic active site formation in plasminogen.
    Gladysheva IP; Sazonova IY; Houng A; Hedstrom L; Reed GL
    Biochemistry; 2007 Jul; 46(30):8879-87. PubMed ID: 17616171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.
    Lucas MA; Straight DL; Fretto LJ; McKee PA
    J Biol Chem; 1983 Oct; 258(20):12171-7. PubMed ID: 6226655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin.
    Doolittle RF; Pandi L
    Biochemistry; 2006 Feb; 45(8):2657-67. PubMed ID: 16489759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of plasminogen activation by lipoprotein(a): critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces.
    Hancock MA; Boffa MB; Marcovina SM; Nesheim ME; Koschinsky ML
    J Biol Chem; 2003 Jun; 278(26):23260-9. PubMed ID: 12697748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A faster-acting and more potent form of tissue plasminogen activator.
    Keyt BA; Paoni NF; Refino CJ; Berleau L; Nguyen H; Chow A; Lai J; Peña L; Pater C; Ogez J
    Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3670-4. PubMed ID: 8170967
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and expression of a gene from kringle-2 domain of tissue plasminogen activator in E. coli.
    Hua ZC; Fu HL; Chen YH; Yu RR; Wang J; Zhu DX
    Sci China B; 1994 Jun; 37(6):667-76. PubMed ID: 7917003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of finger domain and kringle 2 domain of tissue-type plasminogen activator in fibrin binding and stimulation of activity by fibrin.
    Verheijen JH; Caspers MP; Chang GT; de Munk GA; Pouwels PH; Enger-Valk BE
    EMBO J; 1986 Dec; 5(13):3525-30. PubMed ID: 3030730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical and functional characterization of human tissue-type plasminogen activator variants obtained by deletion and/or duplication of structural/functional domains.
    Lijnen HR; Nelles L; Van Hoef B; De Cock F; Collen D
    J Biol Chem; 1990 Apr; 265(10):5677-83. PubMed ID: 2156824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution.
    de Vos AM; Ultsch MH; Kelley RF; Padmanabhan K; Tulinsky A; Westbrook ML; Kossiakoff AA
    Biochemistry; 1992 Jan; 31(1):270-9. PubMed ID: 1310033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
    Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
    Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The structure basis of the poor fibrin specificity of urokinase (II)--The inhibition of urokinase A chain 149-157 on the fibrin stimulated activation of plasminogen by tissue type plasminogen activator.
    Song A; Liu JN; Yu RR; Cui DF; Zhou TM; Cui HR; Zhu DX
    Sci China B; 1992 Aug; 35(8):966-73. PubMed ID: 1338753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis.
    Weening-Verhoeff EJ; Quax PH; van Leeuwen RT; Rehberg EF; Marotti KR; Verheijen JH
    Protein Eng; 1990 Dec; 4(2):191-8. PubMed ID: 1963688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial orientation of tissue-type plasminogen activator bound at the melanoma cell surface.
    Bizik J; Trancikova D; Felnerova D; Verheijen JH; Vaheri A
    Biochem Biophys Res Commun; 1997 Oct; 239(1):322-8. PubMed ID: 9345318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.